Sign in
4

Changes in Ownership

Aardvark Therapeutics, Inc. Filed Acc 0001193125-26-455757

Options or other derivatives

  • Chief Executive Officer acquired 793,951 shares (grant or award)
  • Chief Executive Officer returned 793,951 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Lee Tien-Li · Chief Executive Officer

Table II: Derivative

6 lines
Date Transaction Shares Owned after D/I
2026-11-06 Grant or award : show line 1 in the form Stock Option (right to buy) +203,851 203,851 D
2026-11-06 Returned to the company : show line 2 in the form Stock Option (right to buy) −203,851 0 D
2026-11-06 Grant or award : show line 3 in the form Stock Option (right to buy) +549,534 549,534 D
2026-11-06 Returned to the company : show line 4 in the form Stock Option (right to buy) −549,534 0 D
2026-11-06 Grant or award : show line 5 in the form Stock Option (right to buy) +40,566 40,566 D
2026-11-06 Returned to the company : show line 6 in the form Stock Option (right to buy) −40,566 0 D
Loading xslF345X06/ownership.xml…